Validation of the Hebrew version of the International Parkinson and Movement Disorder Society—unified Parkinson’s disease rating scale (MDS-UPDRS)
Objective: To assess the clinimetric properties of the Hebrew version of the MDS-UPDRS. Background: The Unified Parkinson's disease Rating Scale (UPDRS) is a rating scale…Empowering Parkinson’s patients to declare pain: A multicenter report of the use of the first Parkinson’s pain questionaire (King’s PD pain quest)
Objective: To report the use of the first and easy to use self-completed Parkinson's specific pain questionnaire (King's PD Pain Quest (KPPQ), which is complementary…The International Parkinson and Movement Disorder Society – non-motor rating scale (MDS-NMS): Results from the cognitive pre-testing and phases 1 and 2 of an international validation
Objective: To revise the Non-Motor Sumptom Scale (NMSS) and develop a new up to date version, the MDS-NMS, a project commissioned by the International Parkinson…Validity and reliability of the Turkish version of the scales for outcomes in Parkinson’s disease-autonomic questionnaire (SCOPA-AUT)
Objective: The aim of this study was to evaluate the validity and reliability of the Turkish version of the SCOPA-AUT. Background: The scales for outcomes…Independent validation of the quality of life in essential tremor questionnaire (QUEST)
Objective: We performed an independent testing of the Quality of Life in Essential Tremor Questionnaire (QUEST) adding further information on its clinimetric properties. Background: Essential…Are clinical certainty ratings helpful in the diagnosis of Parkinson’s disease?
Objective: To determine whether clinical certainty ratings are helpful in predicting pathologically proven PD. Background: Clinical diagnostic criteria for PD rely on rest tremor, bradykinesia,…Development of a tool for assessment of embarrassment due to dystonia
Objective: To develop a self assessment scale for quantitative measurement of embarrassment in patients having dystonia. Background: Patients suffering from movement abnormalities like dystonia frequently…Reliability of a newly developed protocol for fiberoptic endoscopic evaluation of swallowing in Parkinson’s patients (PARK-FEES)
Objective: A new FEES protocol specified for dysphagia diagnosis among Parkinson's disease (PD) patients was recently developed in a prior two-phased study¹, which is now…Comparison of change in the UPDRS verses MDS-UPDRS in a population of Parkinson’s disease (PD) patients treated with deep brain stimulation (DBS)
Objective: To compare assessment tools for capturing the therapeutic effect of DBS for treating PD using the original UPDRS and The Movement Disorder Society-sponsored revision…The dopamine agonist withdrawal syndrome rating scale (DAWS-RS): Initial development of a new non-motor scale
Objective: To describe the development of the dopamine agonist withdrawal syndrome (DAWS) rating scale (DAWS-RS), a new questionnaire designed to evaluate the symptoms, severity, and…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.